AB
Anita Bandyopadhyay
About Anita Bandyopadhyay
Data last updated:
Anita Bandyopadhyay is a Director at Vashi Integrated Solutions Limited (since 2024), Director at Shilpa Medicare Limited (since 2022) and Director at Acutaas Chemicals Limited (since 2022), and holds 3 more current directorships. The companies operate in Consumer Electronics & Durables, Pharma and Chemicals and Materials. The 6 current companies with reported revenue have a combined latest revenue of ₹5,390 Cr; the largest is Vashi Integrated Solutions Limited at ₹1,666 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vashi Integrated Solutions Limited U33190MH1991PLC060890 | Director | 29 Mar 2024 | 1991 | ₹1,666 Cr (FY 2024) | Active |
 Shilpa Medicare Limited L85110KA1987PLC008739 | Director | 11 Aug 2022 | 1987 | ₹1,310 Cr (FY 2025) | Active |
 Acutaas Chemicals Limited L24100GJ2007PLC051093 | Director | 08 Feb 2022 | 2007 | ₹1,024 Cr (FY 2025) | Active |
| Shilpa Pharma Lifesciences Limited U24100KA2020PLC134081 | Director | 12 Aug 2022 | 2020 | ₹850 Cr (FY 2025) | Active |
 Speciality Restaurants Limited L55101WB1999PLC090672 | Director | 03 Feb 2020 | 1999 | ₹455 Cr (FY 2025) | Active |
 Shilpa Biologicals Private Limited U24230KA2020PTC131456 | Director | 12 Aug 2025 | 2020 | ₹85.24 Cr (FY 2025) | Active |
Board colleagues of Anita Bandyopadhyay
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anita Bandyopadhyay
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anita Bandyopadhyay
Anita Bandyopadhyay currently holds 6 directorships: Vashi Integrated Solutions Limited (Director, since 29 Mar 2024, revenue ₹1,666 Cr (FY 2024)); Shilpa Medicare Limited (Director, since 11 Aug 2022, revenue ₹1,310 Cr (FY 2025)); Acutaas Chemicals Limited (Director, since 08 Feb 2022, revenue ₹1,024 Cr (FY 2025)); Shilpa Pharma Lifesciences Limited (Director, since 12 Aug 2022, revenue ₹850 Cr (FY 2025)); Speciality Restaurants Limited (Director, since 03 Feb 2020, revenue ₹455 Cr (FY 2025)); and 1 more.
Anita Bandyopadhyay was first appointed on 03 Feb 2020 as Director at Speciality Restaurants Limited. The most recent appointment on record is 12 Aug 2025 at Shilpa Biologicals Private Limited.
The 6 current companies of Anita Bandyopadhyay that report revenue have a combined latest revenue of ₹5,390 Cr: Vashi Integrated Solutions Limited ₹1,666 Cr (FY 2024); Shilpa Medicare Limited ₹1,310 Cr (FY 2025); Acutaas Chemicals Limited ₹1,024 Cr (FY 2025); Shilpa Pharma Lifesciences Limited ₹850 Cr (FY 2025); Speciality Restaurants Limited ₹455 Cr (FY 2025); and 1 more.
The current boards of Anita Bandyopadhyay's companies include Ameet Mohan Dodejaa (Vashi Integrated Solutions Limited), Jatan Madan Dodeja (Vashi Integrated Solutions Limited), Komal Sharma (Vashi Integrated Solutions Limited), Madan Baldev Dodeja (Vashi Integrated Solutions Limited), Manish Ishwarlal Panchal (Vashi Integrated Solutions Limited), Mohan Baldev Dodeja (Vashi Integrated Solutions Limited), among others.